Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 7.24
-0.52 (-6.70%)
Feb 10, 2026, 2:14 PM HKT
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 1.4 billion as of February 13, 2026. Its market cap has decreased by -2.03% in one year.
Market Cap
1.40B
Enterprise Value
1.39B
Revenue
163.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.24
Market Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 1.40B, a decrease of -54.55%. That is a compound annual growth rate of -28.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.40B | -9.73% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhaoke Ophthalmology | 1.90B |
| Cutia Therapeutics | 1.83B |
| Immunotech Biopharm | 1.59B |
| HighTide Therapeutics | 1.47B |
| CANbridge Pharmaceuticals | 1.47B |
| Kintor Pharmaceutical | 1.38B |
| Beijing Biostar Pharmaceuticals | 1.35B |
| Shanghai Bio-heart Biological Technology | 1.31B |